Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
escherichia coli nissle 1917 (3 trials)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Infections (Phase 3)
Stomach Neoplasms (Phase 3)
Trials (3 total)
Trial APIs (1 total)